Carrie S. Cox's Insider Trades & SAST Disclosures
Carrie S. Cox's most recent trade in Texas Instruments Inc. was a trade of 2,551 NQ Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 27, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Carrie S. Cox.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Texas Instruments Inc. | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 2,551 | 2,551 | - | - | NQ Stock Option (Right to Buy) | |
| Texas Instruments Inc. | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 614 | 37,101 (0%) | 0% | 0 | Common Stock | |
| Cartesian Therapeutics Inc | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 8,000 | 8,000 | - | - | Stock Option (Right to Buy) | |
| Cartesian Therapeutics Inc | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 2,600 | 15,629 (0%) | 0% | 0 | Common Stock | |
| Organon & Co. | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 9,638 | 47,059 | - | - | Phantom Stock | |
| Solventum Corp | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 6,336 | 11,484 | - | - | Restricted Stock Units | |
| Solventum Corp | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 5,148 | 5,148 | - | - | Restricted Stock Units | |
| Texas Instruments Inc. | S. Carrie Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 3,066 | 3,066 | - | - | NQ Stock Option (Right to Buy) | |
| Texas Instruments Inc. | S. Cox Carrie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 686 | 36,487 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | S. Carrie Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 248,000 | 248,000 | - | - | Stock Option (Right to Buy) | |
| Selecta Biosciences Inc | Carrie Cox S. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 178,000 | 390,881 (0%) | 0% | 0 | Common Stock | |
| Texas Instruments Inc. | Carrie S. Cox | Director | Sale of securities on an exchange or to another person at price $ 180.04 per share. | 31 Jul 2023 | 16,055 | 35,801 (0%) | 0% | 180.0 | 2,890,542 | Common Stock |
| Texas Instruments Inc. | Carrie S. Cox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.93 per share. | 31 Jul 2023 | 9,990 | 45,791 (0%) | 0% | 52.9 | 528,771 | Common Stock |
| Texas Instruments Inc. | Carrie S. Cox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2023 | 9,990 | 0 | - | - | NQ Stock Option (Right to Buy) | |
| Texas Instruments Inc. | Carrie S. Cox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2023 | 6,065 | 0 | - | - | NQ Stock Option (Right to Buy) | |
| Texas Instruments Inc. | Carrie S. Cox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.26 per share. | 31 Jul 2023 | 6,065 | 51,856 (0%) | 0% | 79.3 | 480,712 | Common Stock |
| Organon & Co. | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 10,086 | 35,232 | - | - | Phantom Stock | |
| Texas Instruments Inc. | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 2,159 | 2,159 | - | - | NQ Stock Option (Right to Buy) | |
| Texas Instruments Inc. | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 574 | 35,801 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 107,500 | 107,500 | - | - | Stock Option (Right to Buy) | |
| Cardinal Health, Inc. | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 2,308 | 41,631 (0%) | 0% | 0 | Common Shares | |
| Selecta Biosciences Inc | Carrie S. Cox | Director | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 13 Jun 2022 | 130,000 | 212,881 (0%) | 0% | 1.2 | 149,799 | Common Stock |
| Organon & Co. | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 5,640 | 24,187 | - | - | Phantom Stock | |
| Texas Instruments Inc. | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 2,512 | 2,512 | - | - | NQ Stock Option (Right to Buy) | |
| Texas Instruments Inc. | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 572 | 35,227 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Selecta Biosciences Inc | Carrie S. Cox | Director | Purchase of securities on an exchange or from another person at price $ 2.95 per share. | 03 Dec 2021 | 17,200 | 82,881 (0%) | 0% | 2.9 | 50,664 | Common Stock |
| Cardinal Health, Inc. | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 3,709 | 39,323 (0%) | 0% | 0 | Common Shares | |
| Organon & Co. | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 18,079 | 18,079 | - | - | Phantom Stock | |
| Selecta Biosciences Inc | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2021 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Texas Instruments Inc. | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 2,457 | 2,457 | - | - | NQ Stock Option (Right to Buy) | |
| Texas Instruments Inc. | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 590 | 34,655 (0%) | 0% | 0 | Common Stock | |
| Cardinal Health, Inc. | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 3,339 | 35,614 (0%) | 0% | 0 | Common Shares | |
| Texas Instruments Inc. | Carrie S. Cox | Director | Sale of securities on an exchange or to another person at price $ 149.31 per share. | 23 Oct 2020 | 22,838 | 34,065 (0%) | 0% | 149.3 | 3,409,978 | Common Stock |
| Texas Instruments Inc. | Carrie S. Cox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.09 per share. | 23 Oct 2020 | 12,299 | 46,364 (0%) | 0% | 44.1 | 542,263 | Common Stock |
| Texas Instruments Inc. | Carrie S. Cox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2020 | 12,299 | 0 | - | - | NQ Stock Option (Right to Buy) | |
| Texas Instruments Inc. | Carrie S. Cox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2020 | 10,539 | 0 | - | - | NQ Stock Option (Right to Buy) | |
| Texas Instruments Inc. | Carrie S. Cox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.94 per share. | 23 Oct 2020 | 10,539 | 56,903 (0%) | 0% | 53.9 | 568,474 | Common Stock |
| Texas Instruments Inc. | Carrie S. Cox | Director | Sale of securities on an exchange or to another person at price $ 130.00 per share. | 24 Jul 2020 | 26,905 | 34,065 (0%) | 0% | 130 | 3,497,650 | Common Stock |
| Texas Instruments Inc. | Carrie S. Cox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.80 per share. | 24 Jul 2020 | 14,749 | 60,970 (0%) | 0% | 32.8 | 483,767 | Common Stock |
| Texas Instruments Inc. | Carrie S. Cox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jul 2020 | 14,749 | 0 | - | - | NQ Stock Option (Right to Buy) | |
| Texas Instruments Inc. | Carrie S. Cox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.36 per share. | 24 Jul 2020 | 12,156 | 46,221 (0%) | 0% | 32.4 | 393,368 | Common Stock |
| Texas Instruments Inc. | Carrie S. Cox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jul 2020 | 12,156 | 0 | - | - | NQ Stock Option (Right to Buy) | |
| Selecta Biosciences Inc | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2020 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges